Erectile Dysfunction in Coronary Artery Disease and Heart Failure
暂无分享,去创建一个
[1] C. Child. Tip of the Iceberg , 2016 .
[2] F. Montorsi,et al. A systematic review of the association between erectile dysfunction and cardiovascular disease. , 2014, European urology.
[3] J. Kostis,et al. Pharmacologic Therapy for Erectile Dysfunction and its Interaction With the Cardiovascular System , 2014, Journal of cardiovascular pharmacology and therapeutics.
[4] E. Loh,et al. Newly diagnosed major depressive disorder and the risk of erectile dysfunction: A population-based cohort study in Taiwan , 2013, Psychiatry Research.
[5] H. Putter,et al. A review of the positive and negative effects of cardiovascular drugs on sexual function: a proposed table for use in clinical practice , 2013, Netherlands Heart Journal.
[6] S. Chrysant. Effectiveness and Safety of Phosphodiesterase 5 Inhibitors in Patients with Cardiovascular Disease and Hypertension , 2013, Current Hypertension Reports.
[7] C. Vlachopoulos,et al. Erectile dysfunction in the cardiovascular patient. , 2013, European heart journal.
[8] Manesh R. Patel,et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. , 2013, JAMA.
[9] C. Vlachopoulos,et al. Plasma total testosterone and incident cardiovascular events in hypertensive patients. , 2013, American journal of hypertension.
[10] F. Montorsi,et al. Erectile dysfunction in heart failure patients: a critical reappraisal , 2013, Andrology.
[11] D. Trivedi,et al. Can simvastatin improve erectile function and health‐related quality of life in men aged ≥40 years with erectile dysfunction? Results of the Erectile Dysfunction and Statins Trial [ISRCTN66772971] , 2013, BJU international.
[12] P. Macdonald,et al. Erectile Dysfunction Severity as a Risk Marker for Cardiovascular Disease Hospitalisation and All-Cause Mortality: A Prospective Cohort Study , 2013, PLoS medicine.
[13] C. Vlachopoulos,et al. Prediction of Cardiovascular Events and All-Cause Mortality With Erectile Dysfunction: A Systematic Review and Meta-Analysis of Cohort Studies , 2012, Circulation. Cardiovascular quality and outcomes.
[14] F. Montorsi,et al. Erectile dysfunction as a cardiovascular risk factor in patients with diabetes , 2013, Endocrine.
[15] C. Tschöpe,et al. Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo , 2012, Basic Research in Cardiology.
[16] S. Heckbert,et al. Erectile dysfunction is not independently associated with cardiovascular death: data from the vitamins and lifestyle (VITAL) study. , 2012, The journal of sexual medicine.
[17] R. Kloner,et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. , 2012, Mayo Clinic proceedings.
[18] Sergio Callegari,et al. Pro-inflammatory genetic profile and familiarity of acute myocardial infarction , 2012, Immunity & Ageing.
[19] M. Susani,et al. Is penile atherosclerosis the link between erectile dysfunction and cardiovascular risk? An autopsy study , 2012, International Journal of Impotence Research.
[20] J. G. Ryan,et al. Erectile dysfunction and its association with metabolic syndrome and endothelial function among patients with type 2 diabetes mellitus. , 2012, Journal of diabetes and its complications.
[21] Z. Mo,et al. The association of smoking and erectile dysfunction: results from the Fangchenggang Area Male Health and Examination Survey (FAMHES). , 2012, Journal of andrology.
[22] Jamie N. Brown,et al. Phosphodiesterase Type 5 Inhibitors as Adjunctive Therapy in the Management of Systolic Heart Failure , 2011, The Annals of pharmacotherapy.
[23] G. Forti,et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. , 2011, European journal of endocrinology.
[24] L. Qin,et al. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. , 2011, Journal of the American College of Cardiology.
[25] D. Calhoun,et al. Aldosterone Blockers (Mineralocorticoid Receptor Antagonism) and Potassium‐Sparing Diuretics , 2011, Journal of clinical hypertension.
[26] M. Ojeda,et al. Imbalanced low-grade inflammation and endothelial activation in patients with type 2 diabetes mellitus and erectile dysfunction. , 2011, The journal of sexual medicine.
[27] A. Abbate,et al. Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoA/Rho-kinase pathway. , 2011, American journal of physiology. Heart and circulatory physiology.
[28] M. Woodward,et al. Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. , 2010, Journal of the American College of Cardiology.
[29] C. Chu,et al. Coronary phenotypes in patients with erectile dysfunction and silent ischemic heart disease: a pilot study. , 2010, The journal of sexual medicine.
[30] C. Vlachopoulos,et al. Cardiovascular aspects of sexual medicine. , 2010, The journal of sexual medicine.
[31] S. Yusuf,et al. Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONT , 2010, Circulation.
[32] C. Stief,et al. Anatomy, physiology, and pathophysiology of erectile dysfunction. , 2010, The journal of sexual medicine.
[33] S. Madersbacher,et al. Is erectile dysfunction a predictor of cardiovascular events or stroke? A prospective study using a validated questionnaire , 2010, International Journal of Impotence Research.
[34] F. Veglia,et al. Erectile dysfunction in heart failure: correlation with severity, exercise performance, comorbidities, and heart failure treatment. , 2009, The journal of sexual medicine.
[35] V. Gentile,et al. Effect of propionyl-l-carnitine, l-arginine and nicotinic acid on the efficacy of vardenafil in the treatment of erectile dysfunction in diabetes , 2009, Current medical research and opinion.
[36] M. Creta,et al. Androgens and morphologic remodeling at penile and cardiovascular levels: a common piece in complicated puzzles? , 2009, European urology.
[37] R. Kloner,et al. Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors , 2009, International Journal of Impotence Research.
[38] L. Lönn,et al. Hydrochlorothiazide, but not Candesartan, Aggravates Insulin Resistance and Causes Visceral and Hepatic Fat Accumulation: The Mechanisms for the Diabetes Preventing Effect of Candesartan (MEDICA) Study , 2008, Hypertension.
[39] M. Böhm,et al. Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome , 2008, International Journal of Impotence Research.
[40] R. Webb,et al. Cigarette smoking and erectile dysfunction: focus on NO bioavailability and ROS generation. , 2008, The journal of sexual medicine.
[41] C. Gazzaruso,et al. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. , 2008, Journal of the American College of Cardiology.
[42] A. Kong,et al. Erectile dysfunction predicts coronary heart disease in type 2 diabetes. , 2008, Journal of the American College of Cardiology.
[43] M. Başar,et al. Effects of statin treatment on serum sex steroids levels and autonomic and erectile function. , 2008, Urology.
[44] E. Jaimes,et al. Thiazide diuretics, endothelial function, and vascular oxidative stress , 2008, Journal of hypertension.
[45] A. Bank,et al. Erectile dysfunction as a harbinger for increased cardiometabolic risk , 2008, International Journal of Impotence Research.
[46] Erasmus Mc,et al. Erectile dysfunction prospectively associated with cardiovascular disease in the Dutch general population: results from the Krimpen Study , 2008, International Journal of Impotence Research.
[47] M. Dowsett,et al. Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study , 2007, Circulation.
[48] C. Vlachopoulos,et al. Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links. , 2007, European urology.
[49] I. Goldstein,et al. Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. , 2007, European urology.
[50] R. Schwinger,et al. NITRIC OXIDE, ERECTILE DYSFUNCTION AND BETA‐BLOCKER TREATMENT (MR NOED STUDY): BENEFIT OF NEBIVOLOL VERSUS METOPROLOL IN HYPERTENSIVE MEN , 2007, Clinical and experimental pharmacology & physiology.
[51] G. Lewis,et al. Sildenafil Improves Exercise Hemodynamics and Oxygen Uptake in Patients With Systolic Heart Failure , 2006, Circulation.
[52] C. Ozdol,et al. Erectile dysfunction may predict coronary artery disease: relationship between coronary artery calcium scoring and erectile dysfunction severity , 2007, International Urology and Nephrology.
[53] J. Floras,et al. The effects of intravenous sildenafil on hemodynamics and cardiac sympathetic activity in chronic human heart failure , 2006, European journal of heart failure.
[54] C. Vlachopoulos,et al. Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. , 2006, European heart journal.
[55] F. Montorsi,et al. Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. , 2006, European heart journal.
[56] F. Montorsi,et al. Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient. , 2006, European urology.
[57] A. L. A S T A I,et al. Erectile dysfunction. , 2006, Harvard men's health watch.
[58] P. Ganz. Erectile dysfunction: pathophysiologic mechanisms pointing to underlying cardiovascular disease. , 2005, The American journal of cardiology.
[59] I. Thompson,et al. Erectile dysfunction and subsequent cardiovascular disease. , 2005, JAMA.
[60] V. Kapur,et al. Why do patients with heart failure suffer from erectile dysfunction? A critical review and suggestions on how to approach this problem , 2005, International Journal of Impotence Research.
[61] C. Vlachopoulos,et al. Prevalence of asymptomatic coronary artery disease in men with vasculogenic erectile dysfunction: a prospective angiographic study. , 2005, European urology.
[62] C. Vlachopoulos,et al. Effect of sildenafil on cardiac performance in patients with heart failure. , 2005, The American journal of cardiology.
[63] R. D'amico,et al. Subclinical Coronary Artery Atherosclerosis in Patients With Erectile Dysfunction , 2005 .
[64] S. Madersbacher,et al. Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke? , 2005, European urology.
[65] E. Barrett-Connor. Heart disease risk factors predict erectile dysfunction 25 years later (the Rancho Bernardo Study). , 2004, The American journal of cardiology.
[66] S. Madersbacher,et al. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. , 2005, European urology.
[67] F. Montorsi,et al. Common grounds for erectile dysfunction and coronary artery disease , 2004, Current opinion in urology.
[68] L. Monti,et al. Nitric-Oxide Mediated Effects of Transdermal Capsaicin Patches on the Ischemic Threshold in Patients with Stable Coronary Disease , 2004, Journal of cardiovascular pharmacology.
[69] A. Guay,et al. Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation. , 2004, The Journal of urology.
[70] S. Necozione,et al. Endothelial cell activation in men with erectile dysfunction without cardiovascular risk factors and overt vascular damage. , 2004, The Journal of urology.
[71] F. Montorsi,et al. Is erectile dysfunction the "tip of the iceberg" of a systemic vascular disorder? , 2003, European urology.
[72] G. Mancia,et al. Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study , 2003, Journal of hypertension.
[73] F. Montorsi,et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. , 2003, European urology.
[74] G. Jackson,et al. eHEART: www.heartjnl.com , 2003 .
[75] G. Jackson,et al. Relation of erectile dysfunction to angiographic coronary artery disease. , 2003, The American journal of cardiology.
[76] H. Krumholz,et al. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. , 2002, JAMA.
[77] E. Bocchi,et al. Sildenafil Effects on Exercise, Neurohormonal Activation, and Erectile Dysfunction in Congestive Heart Failure: A Double-Blind, Placebo-Controlled, Randomized Study Followed by a Prospective Treatment for Erectile Dysfunction , 2002, Circulation.
[78] G. Jackson,et al. IS ERECTILE DYSFUNCTION A MARKER FOR CARDIOVASCULAR DISEASE? , 2001, International journal of clinical practice.
[79] S. Homma,et al. Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure. , 2000, Journal of the American College of Cardiology.
[80] A. Araujo,et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. , 2000, Preventive medicine.
[81] G. Schuler,et al. Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation. , 2000, Journal of the American College of Cardiology.
[82] S. Gardner,et al. The Impact of First‐Line Antihypertensive Drugs on Erectile Dysfunction , 1999, Pharmacotherapy.
[83] S. Kaul,et al. Writing Group Members , 2022 .
[84] S. Kaul,et al. ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association. , 1999, Journal of the American College of Cardiology.
[85] I. Goldstein,et al. A possible mechanism for alteration of human erectile function by digoxin: inhibition of corpus cavernosum sodium/potassium adenosine triphosphatase activity. , 1998, The Journal of urology.
[86] R. Morgan,et al. Does severity of ischemic coronary disease correlate with erectile function? , 1997, International Journal of Impotence Research.
[87] D. Mann,et al. Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart , 1996 .